polytregs
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02772679)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- regulatory t cellsSupplementation
regulatory t cells supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- polytregs
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03444064 | Phase 1 | Feb 1, 2018 | University of Alberta |
| NCT02772679 | Phase 1 | Aug 1, 2016 | University of California, San Francisco, Yale University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Alberta | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1